(Q40548538)

English

Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis anti

scientific article published on 3 October 2003

Statements

Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis anti (English)
Richard Nichols
Sutee Yoksan
Robert Schrader
Chris Murphy
Paul Blum
Stephen Woodward
Karen McCarthy
Danell Mathis
Casey Johnson
Philip Bedford
3 October 2003
1213-1230

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit